Cleared Traditional

K203569 - Gold Tapered Weight Eyelid Implants, Platinum Tapered Weight Eyelid Implants (FDA 510(k) Clearance)

Jun 2021
Decision
186d
Days
Class 2
Risk

K203569 is an FDA 510(k) clearance for the Gold Tapered Weight Eyelid Implants, Platinum Tapered Weight Eyelid Implants. This device is classified as a Weights, Eyelid, Implantable (Class II - Special Controls, product code NCB).

Submitted by Fci (France Chirurgie Instrumentation) Sas (Paris, FR). The FDA issued a Cleared decision on June 11, 2021, 186 days after receiving the submission on December 7, 2020.

This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 886.5700. Gravity Assisted Treatment Of Lagophthalmos (incomplete Eyelid Closure).

Submission Details

510(k) Number K203569 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 07, 2020
Decision Date June 11, 2021
Days to Decision 186 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF

Device Classification

Product Code NCB - Weights, Eyelid, Implantable
Device Class Class II - Special Controls
CFR Regulation 21 CFR 886.5700
Definition Gravity Assisted Treatment Of Lagophthalmos (incomplete Eyelid Closure)